In: Pharmaceutical Research, 2006, vol. 23, no. 8, p. 1850-1856
|
In: Pharmaceutical Research, 1997, vol. 14, no. 9, p. 1252-1257
|
In: Pharmaceutical Research, 2006, vol. 23, no. 6, p. 1117-1132
|
In: Glycobiology, 2011, vol. 21, no. 2, p. 257-268
|
In: Toxicological Sciences, 2012, vol. 125, no. 1, p. 310-317
|
In: American Journal of Epidemiology, 1997, vol. 146, no. 9, p. 734-739
|
In: Biological Chemistry, 2011, vol. 392, no. 11, p. 949-954
|
In: Annals of Oncology, 1997, vol. 8, p. S83-S84
|
In: Euro Nanotox Letters, 2012, vol. 4, no. 01, p. 1-20
The human body can be exposed to nanomaterials through a variety of different routes. As nanomaterials get in contact with the skin, the gastrointestinal tract, and the respiratory tract, these biological compartments are acting as barriers to the passage of nano-sized materials into the organism. These structural and functional barriers are provided by the epithelia serving as an interface...
|
In: Mathematical Biosciences, 2004, vol. 191, p. 207
A model is presented of competition between sensory axons for trophic molecules (e.g. a neurotrophin such as NGF), produced in a region of skin small enough to permit their free diffusion throughout it; e.g., a touch dome, or a vibrissal follicle hair sinus. The variables specified are the number of high affinity trophic factor receptors per axon terminal and the concentration of trophic factor...
|